Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive publishing date : 2021 - 06 - 11 save search
Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine
Published: 2021-06-11 (Crawled : 21:00) - prnewswire.com
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
| Email alert
Add to watchlist
covid positive vaccine
EHA Updates: Companies Share Positive Data in Different Blood Disorders
Published: 2021-06-11 (Crawled : 18:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -0.09%
EQ | $1.77 7.27% 6.78% 88K
|
Health Technology
|
| O: -6.16%
H: 0.31%
C: -6.41%
blood positive
Hycroft Management And Existing Shareholders Increase Positions In Hycroft
Published: 2021-06-11 (Crawled : 16:00) - prnewswire.com
HYMC | $3.83 9.74% 8.88% 470K
|
Non-Energy Minerals
|
| O: 3.3%
H: 5.85%
C: -2.93%
positive
BeiGene Presents Positive Data in Various Lymphomas at EHA2021
Published: 2021-06-11 (Crawled : 15:15) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.01%
H: 0.01%
C: -1.26%
positive presentation
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
Published: 2021-06-11 (Crawled : 12:00) - biospace.com/
EQ | $1.77 7.27% 6.78% 88K
|
Health Technology
|
| O: -6.16%
H: 0.31%
C: -6.41%
disease treatment positive results topline
Curis Announces Positive Updated Data from Ongoing Phase 1/2 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes
Published: 2021-06-11 (Crawled : 12:00) - biospace.com/
CRIS | $14.73 -0.81% -0.81% 5.8K
|
Health Technology
|
| O: -23.82%
H: 0.41%
C: -17.08%
myeloid leukemia ongoing phase 1 positive therapy leukemia phase 3 phase 2 syndros ca-4948 acute myeloid leukemia
Novan Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
Published: 2021-06-11 (Crawled : 11:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 58.85%
H: 30.08%
C: 2.23%
molluscum positive results topline phase 3 trial
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021
Published: 2021-06-11 (Crawled : 08:00) - globenewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
XFOR | $1.225 -9.93% -11.02% 3.5M
|
Health Technology
|
| O: -1.8%
H: 0.97%
C: -5.51%
presentation ongoing phase 1 positive trial phase 1b phase 2b
Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress
Published: 2021-06-11 (Crawled : 08:00) - globenewswire.com
AGIO | $31.82 5.33% 5.06% 1.2M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -3.51%
phase 2 positive results europe positive results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.